✦ LIBER ✦

Vasculitis syndromes: Single dose of rituximab for ANCA-associated vasculitis

Book ID: 123606155
Publisher: Nature Publishing Group
Year: 2014
Tongue: English
Weight: 527 KB
Volume: 10
Category: Article
ISSN: 1759-4790
DOI: 10.1038/nrrheum.2014.52

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction treatment of ANCA associated v

Induction treatment of ANCA associated vasculitis with a single dose of rituximab

✍ Little, M.; Turner-Stokes, T.; Sandhu, E.; Stolagiewicz, N.; Ashley, C.; Salama, 📂 Article 📅 2013 🏛 Masson Editeur 🌐 French ⚖ 89 KB

Induction treatment of ANCA-associated v

Induction treatment of ANCA-associated vasculitis with a single dose of rituximab

✍ Turner-Stokes, T.; Sandhu, E.; Pepper, R. J.; Stolagiewicz, N. E.; Ashley, C.; D 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 236 KB

Rituximab versus Cyclophosphamide for AN

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

✍ Stone, John H.; Merkel, Peter A.; Spiera, Robert; Seo, Philip; Langford, Carol A 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 424 KB

Rituximab versus Cyclophosphamide for AN

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

✍ Stone, John H.; Merkel, Peter A.; Spiera, Robert; Seo, Philip; Langford, Carol A 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 424 KB

## Background: Cyclophosphamide and glucocorticoids have been the cornerstone of remission-induction therapy for severe antineutrophil cytoplasmic antibody (anca)-associated vasculitis for 40 years. uncontrolled studies suggest that rituximab is effective and may be safer than a cyclophosphamide-ba

Rituximab beneficial in ANCA-associated

Rituximab beneficial in ANCA-associated vasculitis

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

S2. Rituximab for ANCA-associated vascul

S2. Rituximab for ANCA-associated vasculitis: The UK experience

✍ Jayne, David 📂 Article 📅 2013 🏛 Masson Editeur 🌐 French ⚖ 111 KB